These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24985359)

  • 21. Pharmacogenetic testing: not as simple as it seems.
    Haga SB; Burke W
    Genet Med; 2008 Jun; 10(6):391-5. PubMed ID: 18496219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring patient and provider perspectives on the intersection between fertility, genetics, and family building.
    Lake PW; Kasting ML; Dean M; Fuzzell L; Hudson J; Carvajal R; Reed DR; Quinn GP; Vadaparampil ST
    Support Care Cancer; 2020 Oct; 28(10):4833-4845. PubMed ID: 31982959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
    Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of a placebo/nocebo effect in pharmacogenetics.
    Haga SB; Warner LR; O'Daniel J
    Public Health Genomics; 2009; 12(3):158-62. PubMed ID: 19204418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial.
    Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO
    Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
    Fabbri C; Zohar J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).
    Bothos E; Ntoumou E; Kelaidoni K; Roukas D; Drakoulis N; Papasavva M; Karakostis FA; Moulos P; Karakostis K
    J Transl Med; 2021 Apr; 19(1):151. PubMed ID: 33858454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center.
    Pasternak AL; Ward KM; Ateya MB; Choe HM; Thompson AN; Clark JS; Ellingrod V
    J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33023029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
    Haga SB; Mills R; Moaddeb J
    Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
    Tuteja S; Haynes K; Zayac C; Sprague JE; Bernhardt B; Pyeritz R
    Per Med; 2013 Nov; 10(8):793-800. PubMed ID: 24409195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical pictograms: a model for development and testing for comprehension and utility.
    Montagne M
    Res Social Adm Pharm; 2013; 9(5):609-20. PubMed ID: 23680485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
    Jameson A; Fylan B; Bristow GC; Sagoo GS; Dalton C; Cardno A; Sohal J; McLean SL
    Front Genet; 2021; 12():740216. PubMed ID: 34630531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
    Winner JG; Carhart JM; Altar CA; Goldfarb S; Allen JD; Lavezzari G; Parsons KK; Marshak AG; Garavaglia S; Dechairo BM
    Curr Med Res Opin; 2015; 31(9):1633-43. PubMed ID: 26086890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics in psychiatry: translating research into clinical practice.
    Malhotra AK; Zhang JP; Lencz T
    Mol Psychiatry; 2012 Jul; 17(8):760-9. PubMed ID: 22083729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis.
    David V; Fylan B; Bryant E; Smith H; Sagoo GS; Rattray M
    Front Genet; 2021; 12():698148. PubMed ID: 34394187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression and Pharmacogenetics.
    Ampong DN
    Arch Psychiatr Nurs; 2018 Feb; 32(1):71-74. PubMed ID: 29413077
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.